Tirapazamine: laboratory data relevant to clinical activity.
about
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group study.Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent.New paradigms and future challenges in radiation oncology: an update of biological targets and technology.DNA strand damage product analysis provides evidence that the tumor cell-specific cytotoxin tirapazamine produces hydroxyl radical and acts as a surrogate for O(2).DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.New Blatter-type radicals from a bench-stable carbene.
P2860
Tirapazamine: laboratory data relevant to clinical activity.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Tirapazamine: laboratory data relevant to clinical activity.
@ast
Tirapazamine: laboratory data relevant to clinical activity.
@en
type
label
Tirapazamine: laboratory data relevant to clinical activity.
@ast
Tirapazamine: laboratory data relevant to clinical activity.
@en
prefLabel
Tirapazamine: laboratory data relevant to clinical activity.
@ast
Tirapazamine: laboratory data relevant to clinical activity.
@en
P1433
P1476
Tirapazamine: laboratory data relevant to clinical activity
@en
P2093
P304
P577
1998-09-01T00:00:00Z